N/A
Completed N=27
A Remote Evaluation of NAVIFY Oncology Hub Using Clinical Simulation
Source: ClinicalTrials.gov NCT05478135 ↗Enrolled (actual)
27
Serious AEs
0.0%
Results posted
Nov 2024
Primary outcomePrimary: System Usability Scale (SUS) — 82 score on SUS
Summary
This work seeks to understand current clinical workflow practice and validate use cases for NAVIFY Oncology Hub.
The main purpose of NAVIFY Oncology Hub is to enhance clinical and operational effectiveness, from diagnostic workup to treatment planning and management. This might free up providers' time and capacity to provide better and more personalized care to patients.
This research protocol builds on previous work that validated clinical simulation methods as a means for clinicians to generate useful insights during the testing and development of digital health tools (Gardner et al. 2020).
Accordingly, this study aims to test the ability of NAVIFY Oncology Hub to increase the work efficiency of oncologists and reduce the cognitive burden/mental fatigue associated with patient care and decision-making.
The insights generated will be used to guide the development of NAVIFY Oncology Hub and optimise user experience, as well as provide a better understanding of the opportunities for it to have maximal impact in the decision-making process.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY System Usability Scale (SUS) |
82 | — |
| PRIMARY Participant-reported Efficiency When Preparing for Patient Consultations, Likert Scale |
26 | — |
| PRIMARY NASA Task Load Index (NASA-TLX) |
17 | — |
| PRIMARY Participant-reported Efficacy of Using Navify Oncology Hub to Facilitate Patient Discussions and Collaborate Care |
21 | — |
| PRIMARY Participant-reported Fidelity of Synthetic Patient Cases |
25 | — |
Eligibility Criteria
Inclusion Criteria
- Board-certified, US-based oncologist
- Minimum 50% spent in clinical practice
- Active member of a tumor board
Exclusion criteria
- Experience using NAVIFY Oncology Hub
- Inability to speak English
Data sourced from ClinicalTrials.gov (NCT05478135). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.